Clinical Trials Sponsored by ImClone LLC

Total 10788 results

MedImmune LLC

Completed

A Clinical Study to Assess the Safety of a New Influenza Vaccine

Healthy

United States
MedImmune LLC

Completed

A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine (MI-MA205)

Healthy

United States
Ischemix, LLC

Completed

Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy (SUPPORT-1)

Percutaneous Coronary Intervention | Stable Coronary Artery Disease

United States, India
Lundbeck LLC

Completed

Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease

Psychotic Disorders | Parkinson's Disease

United States, India, Italy
VIVUS LLC

Terminated

A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®

Hypoactive Sexual Desire Disorder

United States
VIVUS LLC

Completed

Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults

Obesity

United States
VIVUS LLC

Completed

A Phase I Crossover Study of the Hemodynamic Interactions of Avanafil & Alcohol in Healthy Male Subjects.

Erectile Dysfunction
VIVUS LLC

Completed

To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.

Renal
MedImmune LLC

Completed

A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine (MI-MA182)

Influenza

United States
Pharmacyclics LLC.

Completed

Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients

Neoplasms | Hematologic Neoplasms

United States
Lundbeck LLC

Completed

A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy

Epilepsy
MedImmune LLC

Withdrawn

A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer

Breast Cancer

United States
VIVUS LLC

Completed

A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers (TQT)

Torsades de Pointes

United States
VIVUS LLC

Completed

A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.

Obesity

United States
HairDx, LLC

Completed

Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia

Androgenetic Alopecia
VIVUS LLC

Completed

To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil

Erectile Dysfunction

United States
VIVUS LLC

Completed

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Renal Impairment

United States
MedImmune LLC

Completed

Respiratory Events Among Premature Infants

Respiratory Syncytial Virus

United States
MedImmune LLC

Completed

Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis

Psoriasis

United States, Canada
Pharmacyclics LLC.

Completed

A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

Glioma | Glioblastoma | Astrocytoma | Brain Neoplasm | Oligodendroglioma

United States
VIVUS LLC

Completed

Topical Alprostadil for Female Sexual Arousal Disorder

Sexual Dysfunction, Physiological

United States
MedImmune LLC

Completed

Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors

Cancer

France
MedImmune LLC

Completed

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | Leukemia

United States, Israel
MedImmune LLC

Completed

Study of MEDI 507 in the Treatment of Pediatric Patients (Pediatric GvHD)

Graft Versus Host Disease

United States
MedImmune LLC

Completed

A Sequential Dose-Escalation Study in Subjects With Mild Asthma

Asthma

United States
MedImmune LLC

Completed

Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program

Influenza

United States
MedImmune LLC

Withdrawn

A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma

Lymphoma, B-Cell | Lymphoma, Non-Hodgkin
ParaPRO LLC

Completed

NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers

Head Lice

United States
MedImmune LLC

Completed

Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer

Cancer

United States
ParaPRO LLC

Completed

Phototoxicity Potential of NatrOVA Creme Rinse - 1%

Head Lice

United States
MedImmune LLC

Completed

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Prostate Cancer

United States, Belgium, Israel, Russian Federation, Canada, Hungary, Poland
MedImmune LLC

Completed

A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

Plaque Psoriasis

United States, Canada
MedImmune LLC

Completed

Study To Evaluate the Safety of Bivalent Vaccine

Healthy

United States
Pharmacyclics LLC.

Completed

Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors

Breast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Ovarian Neoplasms

United States
Pharmacyclics LLC.

Completed

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Carcinoma, Non-Small-Cell Lung | Brain Neoplasms | Metastases, Neoplasm

United States, France, Belgium, Germany, Canada, Netherlands, Austria, Australia
Janssen Research & Development, LLC
Pharmacyclics LLC.

Recruiting

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia (TAILOR)

Leukemia, Lymphocytic, Chronic, B-Cell | Small Lymphocytic Lymphoma

United States, Italy, Poland, Spain, Czechia, Canada, France
Janssen Research & Development, LLC
Pharmacyclics LLC.

Enrolling by invitation

A Long-term Extension Study of PCI-32765 (Ibrutinib) (CAN3001)

Follicular Lymphoma | Chronic Graft Versus Host Disease | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma

United States, Spain, United Kingdom, Israel, Canada, Belgium, Poland, China, Japan, France, Australia, Russian Federation, Turkey, Sweden, Italy, Mexico, Czechia, Korea, Republic of, Ukraine, Brazil, Hungary, Portugal, Argentina, Col... and more
Janssen Research & Development, LLC
Pharmacyclics LLC.

Active, not recruiting

A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma (VEGA)

Lymphoma, Mantle-Cell

Taiwan, Thailand, Malaysia, India, Puerto Rico, Spain, Turkey, Czechia, Brazil, Greece, Poland, Sweden, Romania
SGX Nova LLC

Completed

SCS Programming Study in Treating Intractable Chronic Back Pain (NOVA) (NOVA)

Chronic Back Pain

United States
Pharmacyclics LLC.
Janssen Research & Development, LLC

Active, not recruiting

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO)

Mantle-Cell Lymphoma

France, Canada, Spain, United States, Hungary, Korea, Republic of, Greece, Australia, Netherlands, Belgium, United Kingdom, Czechia, Germany, Poland, Italy, Turkey, Ukraine
Cancer Insight, LLC
Elios Therapeutics, LLC

Completed

Phase IIB TL + YCWP + DC in Melanoma

Melanoma

United States
Lipac Oncology LLC
TesoRx Pharma, LLC

Completed

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

Urologic Neoplasms | Urogenital Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Non-Muscle Invasive Bladder Cancer | Urinary Bladder | Bladder Cancer Cell Transitional

United States
Grifols Therapeutics LLC
Grifols Biologicals, LLC

Terminated

Alphanate in Immune Tolerance Induction Therapy

Hemophilia A, Congenital

United States, Spain, Italy, India, Canada, Russian Federation
Grifols Therapeutics LLC
Grifols Biologicals, LLC

Completed

Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

United States
Pharmacyclics LLC.
Janssen Research & Development, LLC

Completed

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma

B-cell Lymphoma | Marginal Zone Lymphoma

United States, Belgium, France, Germany, United Kingdom
Neuro-Eye Diagnostic Systems, LLC
Neuro-ophthalmology of Texas PLLC

Enrolling by invitation

Implementation of the NEDS EyeCTester App

Macular Disease | Visual Pathway Disorder | Optic Nerve Disease

United States
LMC Diabetes & Endocrinology Ltd.
Merck Sharp & Dohme LLC; Syreon Corporation

Withdrawn

Approaches To Therapy Escalation In T2D (ATTACC)

Type2 Diabetes
Pramand LLC

Not yet recruiting

CraniSeal Post Approval Study

Leak, Cerebrospinal Fluid
PHARMENTERPRISES LLC

Not yet recruiting

Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis

Cystitis

Russian Federation
Supergene, LLC

Recruiting

Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism

Pulmonary Embolism

Russian Federation

Clinical Trials Sponsored by ImClone LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations